Go Pro

Silexion Therapeutics (SLXN) Institutional Ownership

Silexion Therapeutics logo
$0.42 -0.04 (-8.65%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$0.41 -0.01 (-3.38%)
As of 08/14/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Silexion Therapeutics (NASDAQ:SLXN)

Current
Institutional Ownership
Percentage
10.95%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$76.50K
Number of
Institutional Sellers
(last 12 months)
0
Get SLXN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Silexion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Silexion Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2026Ancora Advisors LLC30,000$31K0.0%N/A7.143%
4/8/2025Meyer Handelman Co.32,967$36K0.0%N/A0.392%
1/29/2025Wildcat Capital Management LLC113,428$228K0.1%-88.9%7.089%
11/9/2024Wildcat Capital Management LLC1,020,852$536K0.3%N/A7.381%


SLXN Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Silexion Therapeutics shares: Wildcat Capital Management LLC ($228K), and Meyer Handelman Co. ($36K), Ancora Advisors LLC ($31K).Learn more on Silexion Therapeutics' institutional investors.

10.95% of Silexion Therapeutics' stock is owned by institutional investors. Learn more on SLXN's institutional investor holdings.

The following institutional investors have purchased Silexion Therapeutics' stock in the last 24 months: Wildcat Capital Management LLC ($1.02M), Meyer Handelman Co. ($32.97K), and Ancora Advisors LLC ($30K).

Institutional investors have bought a total of 30,000 shares in the last 24 months. This purchase volume represents approximately $76.50K in transactions.



Institutional ownership data for NASDAQ:SLXN is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners